For example, tumors and premalignant lesions in both Kras (the most common mutation for adenocarcinoma) and Kras/p53FL/FL models have been shown to be positive for both Sp-B and Sp-C, attesting to the alveolar type II cell origin of the tumors [15,16]. This evidence concerns the gene SFTPB and adenocarcinoma.